MDMA (3,4-methylenedioxy-N-methylamphetamine) for the treatment of tinnitus

The University of Auckland Research Faculty0 个研究点目标入组 40 人开始时间: 2013年6月21日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•constant tinnitus perception
•age between 18 to 70 years
•good mental and physical health – participants cannot take any drug or medication a week before and during the study
•The BMI of each participants must be within 15% of the established norm

•personal, or family history, of mood disorder such as depression or bipolar disorder
•nursing or pregnancy
•history of serious organic illness or major surgery in the three months prior to the study
•smoking more/equal to 20 cigarettes per day
•daily consumption of alcohol greater/equal to 50 g
•taking medication regularly in a month previous to the study
•history of allergy or adverse reaction to medication
•neurological disorders susceptible to worsening with psychoactive substances e.g. epilepsy
•history of cardio-vascular, gastro-intestinal, hepatic, or renal pathology or of any other type that suggest an alteration in the absorption, distribution, metabolisms or excretion of the medication, or which suggests heightened gastro-intestinal sensitivity to medication
•systolic blood pressure higher/equal to 135, diastolic blood pressure higher/equal to 85 or heart rate higher/equal to 100 bpm after 5 min rest
•inability to understand the nature and consequences of the study or the procedures
•history of drug or alcohol addiction

发起方

The University of Auckland Research Faculty